CORE--Clinical Core

CORE--临床核心

• 批准号: 6900242
• 负责人: Martin H. Steinberg
• 金额: $ 32.94万
• 依托单位: BOSTON MEDICAL CENTER
• 依托单位国家: 美国
• 财政年份: 2004
• 资助国家: 美国
• 起止时间: 2004-05-20 至 2008-03-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6900242
• 关键词: biomedical facility; clinical trials; cooperative study; medical outreach /case finding; patient care; sickle cell anemia

Aims of our Clinical Core are to provide access to a large group of patients with sickle cell disease who will be potentially available for collaborative inter-center clinical trials and for the studies of investigators within the Boston Comprehensive Sickle Cell Center. We will also deliver the highest level of patient care available by assuring access to physicians and nurses specially trained in managing hemoglobinopathies who are aware of the most recent advances in sickle cell disease treatment. Three medical centers in Boston, Boston Medical Center, Brigham and Women's Hospital and Children's Hospital, and, the University of Mississippi Medical Center provide access to more than 1600 patients with sickle cell disease. Each component of the Clinical Core is staffed by one or more physicians experienced in the care of patients with sickle cell disease and by a similarly experienced nursing staff. Each clinic has a long and successful record of participation in clinical trials in sickle cell disease.

我们临床核心的目标是为大量镰状细胞病患者提供接触机会，这些患者将有可能参与中心间协作临床试验以及波士顿综合镰状细胞中心内的研究人员的研究。我们还将确保提供接受过血红蛋白病治疗方面专门培训的医生和护士，他们了解镰状细胞病治疗的最新进展，从而提供最高水平的患者护理。波士顿的三个医疗中心：波士顿医疗中心、布莱根妇女医院和儿童医院以及密西西比大学医疗中心为 1600 多名镰状细胞病患者提供服务。临床核心的每个组成部分均由一名或多名在镰状细胞病患者护理方面经验丰富的医生以及经验相似的护理人员组成。每个诊所都有参与镰状细胞病临床试验的长期成功记录。